report
evalu
cytotox
seri
electrondefici
halfsandwich
preciou
metal
complex
ruthenium
osmium
iridium
osru
p
toward
raw
murin
macrophag
fibroblast
cell
complex
found
noncytotox
antiinflammatori
activ
evalu
cell
line
nitric
oxid
product
inflamm
respons
induc
bacteri
endotoxin
lipopolysaccharid
lp
stimulu
metal
complex
shown
exhibit
dosedepend
inhibitori
effect
lpsinduc
product
cell
line
remark
two
iridium
complex
trigger
full
antiinflammatori
respons
lpsinduc
product
open
new
avenu
develop
noncytotox
antiinflammatori
drug
candid
distinct
structur
solut
chemistri
organ
drug
potenti
novel
mechan
action
inflamm
bodi
natur
protect
respons
tissu
injuri
caus
physic
chemic
stimuli
invad
microbi
toxin
prolong
inflamm
lead
chronic
inflammatori
diseas
asthma
rheumatoid
arthriti
multipl
sclerosi
parkinson
alzheim
diseas
cancer
proinflammatori
cell
mainli
activ
macrophag
produc
inflammatori
cytokin
inflammatori
mediat
includ
overproduct
nitric
oxid
process
inflamm
inflamm
initi
trigger
stimul
lipopolysaccharid
lp
tumour
necrosi
factoralpha
interferongamma
exposur
stimul
product
inflammatori
cytokin
increas
activ
macrophag
therefor
inhibit
product
major
target
antiinflammatori
drug
discoveri
nonetheless
sever
sideeffect
associ
current
antiinflammatori
drug
utmost
import
develop
new
antiinflammatori
compound
less
sideeffect
differ
mechan
action
metal
coordin
complex
offer
versatil
platform
design
drug
potenti
uniqu
mechan
action
larg
pool
metalbas
drug
aris
varieti
metal
oxid
state
overal
coordin
geometri
use
design
number
type
ligand
strong
influenc
activ
synthes
metal
complex
although
ancient
util
metal
ion
metal
complex
medicin
quit
recent
stimul
clinic
success
cisplatin
platinum
ii
anticanc
drug
util
gadolinium
complex
mri
contrast
agent
mtechnetium
radiopharmaceut
imag
larg
structur
divers
metal
complex
also
attract
platform
drug
design
diseas
condit
includ
neurodegener
microbi
parasit
infect
inflamm
recent
survey
signific
number
clinic
trial
involv
metal
compound
therapi
diagnosi
context
clear
metal
complex
potenti
offer
altern
antiinflammatori
organ
drug
gold
complex
auranofin
approv
fda
oral
antiarthrit
agent
although
still
fulli
elucid
mechan
action
believ
involv
inhibit
cathepsin
b
bismuth
complex
effect
toward
number
diseas
syphili
main
use
bismuth
therapi
inhibit
helicobact
pylori
helicobact
pylori
bacterium
prevent
ulcer
heal
owe
develop
antibiot
drug
resist
h
pylori
tripl
quadrupl
regimen
base
two
antibiot
acidsuppress
agent
bismuth
salt
investig
treatment
bacterium
halfsandwich
metal
complex
ruthenium
osmium
iridium
versatil
famili
organometal
biolog
properti
rais
consider
expect
treatment
cancer
sinc
begin
consid
promis
altern
platinumbas
chemotherapeut
recent
develop
strong
interest
chemic
biolog
properti
electrondefici
halfsandwich
complex
particular
complex
base
carboran
ligand
os
pcymen
ru
pcymen
figur
shown
highli
activ
toward
ovarian
cancer
cell
benzenedithiolato
analogu
os
pcymen
ru
pcymen
figur
recent
shown
exhibit
low
reactiv
ligand
solut
lack
reactiv
toward
pyridin
deriv
particular
found
relat
aromat
fivememb
ms
c
chelat
ring
involv
sulfur
lone
pair
bond
ms
c
chelat
ring
report
evalu
cytotox
electrondefici
metal
complex
iridium
analogu
ir
pentamethylcyclopentadien
benzenedithiol
analogu
ir
pentamethylcyclopentadien
figur
toward
raw
murin
macrophag
fibroblast
cell
two
cell
line
wide
use
vitro
model
studi
inflamm
antiinflammatori
activ
evalu
cell
line
inflamm
respons
trigger
bacteri
endotoxin
lipopolysaccharid
stimulu
dulbecco
modifi
eagl
medium
dmem
fetal
bovin
serum
fb
penicillin
streptomycin
phosphatebuff
salin
pb
ph
tissu
cultur
reagent
purchas
gibco
thermo
fisher
scientif
uk
lp
bromid
mtt
griess
reagent
purchas
promega
chemic
purchas
sigmaaldrich
uk
deposit
formazon
optic
densiti
od
well
measur
nm
micropl
reader
dynex
technolog
concentr
cultur
medium
determin
via
griess
reaction
specif
supernat
well
mix
griess
reagent
sulfanilamid
phosphor
acid
naphthylethylenediamin
dihydrochlorid
water
separ
plate
incub
min
ambient
temperatur
optic
densiti
determin
nm
micropl
reader
result
least
three
independ
experi
present
mean
sd
standard
deviat
signific
differ
examin
use
analysi
varianc
anova
student
ttest
spss
v
softwar
spss
inc
chicago
il
usa
atmospher
solid
analysi
probe
mass
spectroscopi
asapm
experi
perform
micromass
zmd
mass
spectromet
mass
analysi
perform
posit
ioniz
mode
set
follow
sourc
temperatur
sampl
cone
v
corona
kv
uvvis
spectroscopi
carri
perkinelm
lambda
uvvis
spectromet
agil
cari
uvvis
spectrophotomet
quartz
cell
two
polish
side
use
cellular
viabil
raw
macrophag
cell
presenc
complex
first
investig
figur
b
complex
show
slightli
reduc
cell
viabil
h
compound
treatment
except
complex
induc
signific
chang
cell
viabil
test
concentr
cytotox
effect
complex
found
dosedepend
figur
interestingli
cytotox
observ
compound
h
includ
h
recoveri
test
chosen
concentr
figur
cytotox
complex
toward
raw
cell
presenc
lp
ml
h
without
recoveri
time
figur
h
h
recoveri
time
figur
investig
via
mtt
assay
h
treatment
complex
presenc
lp
found
lp
significantli
reduc
viabil
raw
cell
ctrl
versu
lp
complex
also
show
reduc
cell
viabil
slightli
vari
respons
among
compar
lp
group
figur
c
complex
exhibit
concentrationdepend
inhibit
complex
concentrationindepend
interestingli
cell
allow
h
recoveri
compound
exhibit
cytotox
toward
raw
cell
except
slight
weak
recoveri
observ
complex
figur
fibroblast
cell
line
use
investig
effect
complex
cell
viabil
cell
typespecif
test
cell
viabil
h
incub
complex
without
recoveri
time
figur
h
period
recoveri
figur
previous
report
complex
found
highli
cytotox
toward
cell
strong
doseindepend
cytotox
effect
observ
even
nitric
oxid
product
induc
lp
reflect
degre
inflamm
chang
level
provid
mean
assess
effect
agent
inflammatori
process
determin
effect
complex
lpsinduc
product
raw
cell
cell
cultur
medium
harvest
product
measur
use
griess
reaction
figur
lpsinduc
product
significantli
decreas
presenc
complex
dosedepend
manner
test
concentr
except
complex
concentr
concentr
lpsinduc
product
measur
lpsinduc
cell
figur
similarli
lpsinduc
product
found
significantli
decreas
presenc
complex
dosedepend
manner
test
concentr
except
complex
concentr
complex
found
exhibit
inhibitor
effect
lpsinduc
product
test
concentr
interestingli
case
iridium
complex
decreas
product
reach
level
control
cell
untreat
lp
complex
suggest
full
antiinflamm
effect
two
compound
confirm
abil
electrondefici
metal
complex
interact
nitric
oxid
reactiv
complex
solut
studi
bubbl
aceton
solut
complex
reveal
mz
peak
correspond
fragment
precursor
electron
supplementari
materi
figur
electrondefici
organometal
play
key
role
intermedi
organometal
reaction
also
known
extrem
unstabl
organometal
follow
rule
stabl
coordin
unsatur
monom
speci
owe
steric
hindranc
bulki
carboran
prevent
dimer
compound
format
electron
favour
speci
complex
react
ligand
give
complex
complex
ruo
pcym
triphenylphosphin
react
aromat
amin
dichloromethan
chloroform
solut
ambient
temperatur
blue
ru
red
os
complex
equilibrium
yellow
adduct
thermal
displac
equilibrium
result
mark
thermochrom
properti
owe
unusu
reactiv
solut
anticip
complex
may
possess
interest
biolog
properti
recent
report
potent
antiprolif
activ
complex
toward
ovarian
cancer
cell
howev
effect
complex
proinflammatori
mediat
secret
macrophag
fibroblast
report
present
studi
investig
cytotox
complex
antiinflammatori
activ
lipopolysaccharid
lp
activ
raw
macrophag
fibroblast
cell
complex
serv
highli
potent
micromolar
nanomolar
rang
select
inhibitor
kinas
osmium
heavier
congen
ruthenium
third
row
transit
metal
commonli
exhibit
slower
kinet
ruthenium
often
consid
rel
inert
howev
possibl
tune
biochem
reactiv
aren
os
ii
complex
understand
aqueou
solut
chemistri
previous
report
os
complex
prompt
react
ligand
ruthenium
halfsandwich
complex
usual
reactiv
osmium
counterpart
activ
via
redox
pathway
ligand
substitut
fine
control
offer
activ
complex
reach
target
although
mechan
action
cytotox
complex
unknown
current
investig
seem
clear
electron
defici
complex
allow
interact
number
biomolecul
en
rout
cell
work
illustr
abil
studi
reactiv
complex
hypothes
reason
antiinflammatori
effect
absenc
cytotox
iridium
complex
may
due
greater
inert
slower
kinet
ir
ru
os
analogu
accord
recent
studi
reactiv
complex
toward
ligand
exampl
complex
present
monomer
speci
solut
less
kinet
inert
complex
present
monomer
dimer
structur
solut
therefor
iridium
complex
could
react
excel
ligand
owe
bond
steric
consider
larg
biomolecul
kinet
activ
ru
os
analogu
could
react
also
target
eg
glutathion
lead
cytotox
impact
natur
metal
ion
evidenc
fact
two
ruthenium
complex
similar
effect
cellular
viabil
raw
macrophag
cell
concentr
two
osmium
complex
exhibit
slight
dosedepend
cytotox
toward
fibroblast
cell
strike
result
term
structureact
relationship
cytotox
complex
toward
two
differ
cell
line
observ
iridium
complex
show
cytotox
effect
concentr
tabl
inhibit
product
lpsinduc
raw
macrophag
fibroblast
cell
compound
inhibit
effect
repres
molar
concentr
give
inhibit
ic
rel
control
ic
valu
determin
plot
product
percentag
control
yaxi
complex
concentr
xaxi
data
figur
data
repres
averag
valu
three
independ
experi
high
hydrophob
dicarbaclosododecarboran
dicarbaclosododecarboran
deriv
use
pharmacophor
enhanc
hydrophob
interact
pharmaceut
compound
oestrogen
retinoid
receptor
hydrophob
complex
therefor
expect
much
higher
one
benzen
analogu
remark
cytotox
result
complex
cell
line
highlight
dramat
differ
activ
two
carboranecontain
group
viii
metal
ru
os
complex
metal
complex
studi
work
complex
show
concentrationdepend
inhibit
toward
raw
cell
treat
lp
ml
activ
metal
complex
found
concentrationindepend
two
complex
compound
exhibit
signific
cytotox
effect
fibroblast
cell
treat
lp
seem
clear
main
factor
activ
two
seri
electrondefici
halfsandwich
metal
complex
therefor
seem
role
metal
ion
ir
carboran
complex
noncytotox
despit
incorpor
dicarbaclosododecarboran
noninnoc
ligand
effect
chelat
ligand
although
less
pronounc
influenc
natur
metal
ion
nonetheless
import
exemplifi
dramat
differ
behaviour
carboraneand
benzenecontain
os
ru
complex
versu
versu
remark
antiinflammatori
activ
differ
complex
follow
trend
structureact
relationship
antiprolif
one
carboraneand
benzenecontain
ru
os
complex
versu
versu
show
stark
differ
abil
decreas
lpsinduc
product
final
note
complex
neutral
similar
solubl
mixtur
v
v
dmso
water
use
biolog
test
similarli
cytotox
result
two
iridium
complex
display
remark
differ
behaviour
compar
ruthenium
osmium
analogu
iridium
complex
addit
noncytotox
possess
abil
reduc
product
level
control
assay
cell
untreat
lp
complex
indic
two
compound
toxic
offer
full
antiinflamm
protect
cell
differ
antiinflammatori
activ
notic
depend
cell
type
particularli
term
inhibit
lpsinduc
product
although
complex
display
dosedepend
inhibitori
effect
lpsinduc
product
cell
line
compound
found
greater
potenti
inhibit
product
cell
regardless
metal
ion
ligand
raw
cell
evidenc
molar
concentr
valu
give
inhibit
ic
rel
control
tabl
cytotox
antiinflammatori
effect
six
electrondefici
halfsandwich
metal
complex
ruthenium
osmium
iridium
toward
lpsinduc
raw
macrophag
fibroblast
cell
investig
six
metal
complex
shown
exhibit
dosedepend
inhibitori
effect
lpsinduc
product
cell
line
remark
two
iridium
complex
ir
pentamethylcyclopentadien
ir
pentamethylcyclopentadien
found
noncytotox
trigger
full
antiinflammatori
respons
toward
lpsinduc
product
hypothes
electrondefici
configur
metal
centr
allow
bind
ligand
metal
ion
extent
bind
implic
toward
antiinflammatori
mechan
action
complex
investig
futur
work
antiinflammatori
effect
noncytotox
complex
potenti
use
treatment
sever
infecti
diseas
trigger
inflamm
fibrosi
end
stage
like
sar
sever
acut
respiratori
syndrom
fatal
diseas
without
effect
antivir
agent
avail
anoth
diseas
endur
similar
patholog
chang
chronic
liver
infecti
diseas
like
hepat
c
also
poor
prognosi
without
proper
treatment
avail
therefor
two
iridium
compound
potenti
use
control
progress
sever
diseas
comparison
cortison
similar
antiinflammatori
effect
caus
side
effect
osteonecrosi
femor
head
high
dosag
